期刊文献+

p53基因突变对非小细胞肺癌TSG101/MDM2信号通路的影响 被引量:6

Effect of Gene Mutation of p53 in Lung Cancer on TSG101/MDM2 Signal Passway
在线阅读 下载PDF
导出
摘要 目的探讨p53基因突变在肺癌中对TSG101/MDM2信号通路影响的临床病理学意义。方法采用免疫组织化学方法检测185例肺癌组织标本中TSG101、MDM2及p53的表达,用聚合酶链反应单链构象多态性(Polymerase Chain Reaction,single-strand conformation polymorphism,PCR-SSCP)分析法检测p53突变情况,以及Western blot检测TSG101在肺癌组织和正常肺组织中的表达。结果 (1)肺癌组中p53蛋白的总阳性率为80.54%(149/185),PCR-SSCP检测结果显示总突变率为56.67%(17/30),p53蛋白表达与病理分期、淋巴结转移有相关性(P<0.05);TSG101蛋白的低表达率为58.92%(109/185),Western blot结果显示TSG101在癌组织中的表达明显低于对照组(P<0.05),TSG101蛋白表达与病理分期、分化、淋巴结转移有相关性(P<0.05);MDM2蛋白的过表达率为77.84%(144/185),MDM2蛋白表达与病理分期、淋巴结转移有相关性(P<0.05)。(2)在p53阳性的149例中TSG101阳性76例,MDM2阳性139例,在p53阴性的36例中TSG101阳性33例,MDM2阳性5例。p53与TSG101两者共表达率为41.08%,一致性为42.70%。p53与MDM2两者共表达率为75.14%,一致性为91.89%。结论 (1)p53/MDM2上调与TSG101表达下调肺癌的发生及生物学行为有关。(2)当p53突变时,TSG101与MDM2的表达呈负相关关系。 Objective To explore the clinical pathology effect of gene mutation of p53 in lung cancer on TSG101/MDM2 signal passway.Methods Immunohistochemical method was adopted to detect the expression of TSG101,MDM2 and p53 in lung cancer tissues of 185 cases.PCR-SSCP was used to detect the gene mutation of p53.Western blot method was adopted to detect the expression of TSG101 in tumor tissues and normal tissues.Results(1)The overall positive rate of p53 protein in the group of cancer was 80.54%(149/185).The result of PCR-SSCP showed that the overall mutation rate was 56.67%(17/30).The expression of p53 protein had correlation with the stages of pathology and the lymph node(P0.05).The low expression rate of TSG101 protein was 58.92%(109/185).The result of Western blot showed that the expression of TSG101 in the group of cancer tissues was significantly lower than that in the control group(P0.05).The expression of TSG101 protein had correlation with the stages of pathology,differentiation and lymph node metastasis(P0.05).The excess expression rate of MDM2 protein was 77.84%(144/185).The expression of MDM2 protein had correlation with the stages of surgery pathology and lymph node metastasis(P0.05).(2)There were 76 cases of TSG101 positive and 139 cases of MDM2 positive in the 149 cases p53 positive,respectively.There were 3 cases of TSG101 negative and 31 cases of MDM2 negative in the 36 cases of p53 negative,respectively.The altogether expression rate was 91.89%.Conclusion(1)The up-regulated expression of p53/MDM2 and decline of TSG101 have correlation with the occurrence of lung cancer and its biology behavior.(2) When p53 gene is mutation,the expression of TSG101 and MDM2 is negative correlation.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2011年第7期774-777,共4页 Cancer Research on Prevention and Treatment
基金 河南省教育厅重点科研课题资助项目(2006310024) 新乡市科技局重点科研课题资助项目(07S050)
关键词 肺癌 p53 TSG101 MDM2 免疫组织化学 WESTERN BLOT PCR-SSCP Lung cancer p53 TSG101 MDM2 Immunohistochemistry Western blot PCR-SSCP
作者简介 作者简介:杨廷桐(1953-),男,硕士,教授,主要从事肺癌发生与阻断的研究
  • 相关文献

参考文献9

  • 1杨廷桐,武俊芳,李秀杰,范文艳,汪艳丽.非小细胞肺癌中p14ARF和mtp53蛋白表达与临床病理参数的关系[J].新乡医学院学报,2008,25(4):336-339. 被引量:1
  • 2Li L,Liao J,Ruland J,et al. A TSG101/MDM2 regulatory loop modulates MDM2 degradation and MDM2/p53 feedback con- trol[J]. Proc Natl Acad Sei USA,2001,98(4) : 1619-1624.
  • 3Cheng TH,Cohen SN. Human MDM2 is oforms translated dif- ferentially on constitutive versus p53-regulated transcripts have distinct functions in the p53/MDM2 and TSG101/MDM2 feedback control loops[J]. Mol Cell Biol, 2007, 27 (1) : 111- 119.
  • 4Ventura A, Kirsch IX3, McLaughlin ME, et al. Restoration of p53 funtion leads to tumor regression in vivo[J]. Nature, 2007,445 ( 7128 ) : 661-665.
  • 5祖金池,李文艳,段斐.原癌基因和抑癌基因在肺癌中的研究进展[J].肿瘤防治研究,2009,36(9):804-807. 被引量:2
  • 6Wang H,Nan L, Yu D, et al. Antisense anti-MDM2 oligonu- cleotide as a novel therapeutic approach to human breast canc- er:in vitro and in vivo activities and mechanisms[J]. Clin Cancer Res, 2001,7 (l 1 ) : 3613-3624.
  • 7杨廷桐,张骏,郑杰,吴秉铨.人小细胞肺癌P^(53)基因突变的研究[J].肿瘤防治研究,1998,25(6):445-447. 被引量:3
  • 8Feng GH, Lili CJ, Cohen SN. TSC-101 Protein steady-state lev- el is regulated posttranslationally by an evolutionarily con- served COOH-terminal sequence. [J]. Cancer Res, 2000, 60 (6) : 1736-1741.
  • 9Lippman SM,Spitz MR. Lung cancer chemo prevention: an te- grated approach[J]. J Clin Oncol, 2001,19 (18 suppl) : 74s-82s.

二级参考文献44

共引文献3

同被引文献48

  • 1单秀红,郑金旭,王绪,彭卫斌.非小细胞肺癌的CT增强值与p53表达的关系研究[J].中国肿瘤临床,2004,31(17):993-996. 被引量:3
  • 2宋丽萍,邱曙东.P53-mdm2相互作用与肿瘤治疗策略[J].中国肿瘤生物治疗杂志,2005,12(4):303-305. 被引量:2
  • 3程晓华,熊玉卿.五环三萜皂苷的药理作用研究进展[J].中草药,2007,38(5):792-795. 被引量:59
  • 4赵长久,付鹏,盛云霞,韩巍,李忠源.^(99)Tc^m标记MDM2反义寡核苷酸的实验研究[J].中华核医学杂志,2007,27(4):195-201. 被引量:3
  • 5Cahilly-Snyder L, Yang-Feng T, Francke U, et al. Molecular a- nalysis and chromosomal mapping of amplified genes isolated from a transformed mouse 3T3 cell line [ J ]. Somat Cell Mol Genet, 1987, 13 (3): 235-244.
  • 6Liu G, Wheatley-Price P, Zhou W, et al. Genetic polymor- phisms of MDM2, cumulative cigarette smoking and nonsmall cell lung cancer risk [J]. Int J Cancer, 2008, 122 (4): 915- 918.
  • 7Wang X, Zhang X, Qiu B, et al. MDM2 SNP309T > G polymor- phism increases susceptibility to hepatitis B virus-related hepatocel- lular carcinoma in a northeast Han Chinese population [ J ]. Liver Int, 2012, 32 (7): 1172-1178.
  • 8Song B, Duan ZY, Zhong YH, et al. Meta-ana!ysis of the MDM2 T309G polymorphism and gastric cancer risk [ J]. Asian Pac J Cancer Prev, 2013, 14 (11): 6649-6651.
  • 9Olsson H, Hultman P, Rosell J, et al. MDM2 SNP309 promot- er polymorphism and p53 mutations in urinary bladder carcinoma stageT1 [J]. BMC Uml, 2013, 13: 5.
  • 10Jiang T, Zhou C, Gu J, et al. Enhanced therapeutic effect of cisplatin on the prostate cancer in tumor-bearing mice by transfect- ing the attenuated Salmonella carrying a plasmid co-expressing p53 geneand mdm2 siRNA [J]. Cancer Lett, 2013, 337 (1): 133 - 142.

引证文献6

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部